← Leaderboards
Zhaohui Gu
St. Jude Children'S Research Hospital
$1,837,199
Attributed
$1,837,199
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,837,199 · 4
By mechanism
R00$747,000 · 1
R37$517,090 · 1
R01$483,110 · 1
K99$89,999 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Charles G. Mullighan$25,123,215
- Mary V. Relling$28,942,987
- Madeline Niederkorn$435,684
- Nicole Michmerhuizen$690,457
- Charalampos Kalodimos$19,497,370
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesMouse ModelTranscriptome SequencingSamplingOverexpressionPathway InteractionsPhosphotransferasesSubgroupLeukemiaAdultMalignant Childhood NeoplasmLesionAffectLeukemogenesisCodeKnock-In MouseGenomicsBinding SitesGenome SequencingIndividualized MedicineAtac-SeqChemotherapyB-LymphocytesGenetic Signature
Grant awards (6)
The Role and Function of a Novel Signature Gene in BCR::ABL1 (Ph) B-cell Acute Lymphoblastic Leukemia$517,090
R37 · FY2025 · CA · contact PI
Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia$483,110
R01 · FY2025 · CA · contact PI
Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia$249,000
R00 · FY2022 · CA · contact PI
Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia$249,000
R00 · FY2021 · CA · contact PI
Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia$249,000
R00 · FY2020 · CA · contact PI
Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia$89,999
K99 · FY2019 · CA · contact PI